ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,309.27
-0.03%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Kaya Holdings Inc (QB) (KAYS)

  7. Kaya Holdings Inc (QB) (KAYS) News

Kaya (QB) (KAYS)

Kaya Holdings Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:KAYS
DateTimeSourceHeadlineSymbolCompany
07/06/202414:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
16/05/202421:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:KAYSKaya Holdings Inc (QB)
10/05/202413:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
15/02/202421:38Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:KAYSKaya Holdings Inc (QB)
28/11/202312:00InvestorsHub NewsWireInvestor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental HealthUSOTC:KAYSKaya Holdings Inc (QB)
20/11/202322:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:KAYSKaya Holdings Inc (QB)
09/11/202313:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
23/10/202321:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
03/10/202312:48Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
21/08/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:KAYSKaya Holdings Inc (QB)
14/08/202313:44Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:KAYSKaya Holdings Inc (QB)
24/05/202314:48InvestorsHub NewsWireKaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.USOTC:KAYSKaya Holdings Inc (QB)
22/05/202321:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:KAYSKaya Holdings Inc (QB)
19/05/202321:07Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:KAYSKaya Holdings Inc (QB)
15/05/202321:29Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:KAYSKaya Holdings Inc (QB)
15/05/202315:29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
27/04/202319:52Edgar (US Regulatory)Annual Report (10-k)USOTC:KAYSKaya Holdings Inc (QB)
13/03/202312:33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
21/02/202311:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
15/02/202313:45InvestorsHub BioTech NewsWireKaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center ™ to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics ™ Mind Care ClinicsUSOTC:KAYSKaya Holdings Inc (QB)
15/02/202313:45InvestorsHub NewsWireKaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center ™ to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics ™ Mind Care ClinicsUSOTC:KAYSKaya Holdings Inc (QB)
30/01/202313:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
25/01/202315:53InvestorsHub NewsWireKaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics MarketUSOTC:KAYSKaya Holdings Inc (QB)
14/11/202220:57Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:KAYSKaya Holdings Inc (QB)
15/09/202221:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:KAYSKaya Holdings Inc (QB)
22/08/202221:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:KAYSKaya Holdings Inc (QB)
04/08/202217:44InvestorsHub NewsWireKaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in OregonUSOTC:KAYSKaya Holdings Inc (QB)
07/07/202218:11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
30/03/202221:20Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:KAYSKaya Holdings Inc (QB)
29/12/202119:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
 Showing the most relevant articles for your search:USOTC:KAYS

Your Recent History

COIN
DGENUSD
DEGEN
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved